Electrochemical reaction-based stimuli-responsive materials are shaping up the era of innovative display devices. By embedding luminescent europium(III) complexes and color-changing viologen ...
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...